Safety and effectiveness of vaccines agains SARS-COV-2 in patients with liver cancer. VacHep registry: response analysis 4 weeks after the second dose.

Detalles Bibliográficos
Autores principales: Sempere, Elena Diago, Matilla, Ana, Rodríguez, Carlos, Perelló, Christie, Minguez, Beatriz, Varela, Maria, Urquijo, Juan José, Ampuero, Javier, Prieto, Janire, Pérez, Laura Márquez, Crespo, Javier, Bermúdez, María, Piedra Cerezal, Ana Maria, Diago, Moises, Antoran, Belén Ruiz, Calleja Panero, José Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association for the Study of the Liver. Published by Elsevier B.V. 2022
Materias:
POSTER PRESENTATIONS: Saturday 25 June: Liver tumours: Clinical aspects except therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252397/
http://dx.doi.org/10.1016/S0168-8278(22)02112-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252397/
http://dx.doi.org/10.1016/S0168-8278(22)02112-2

Ejemplares similares